Expression profile and prognostic values of SMC family members in HCC.

Wei YanDan-Dan WangHe-Da ZhangJinny HuangJun-Chen HouSu-Jin YangJian ZhangLing LuQian Zhang

Published in: Medicine (2022)

In this study, we comprehensively analyzed the expression of SMC family members in patients with HCC. This can provide insights for further investigation of the SMC members as potential therapeutic targets in HCC and suggest that the use of SMC inhibitor targeting SMC2, SMC3, and SMC4 can be a practical strategy for the therapy of HCC.

Keyphrases

stem cells
drug delivery
risk assessment
cancer therapy
binding protein
cell therapy